Abstract:
Die Erfindung betrifft substituierte Tetrahydronaphthaline und deren Derivate, sowie deren physiologisch verträgliche Salze und physiologisch funktionelle Derivate, deren Herstellung, Arzneimittel enthaltend mindestens ein erfindungsgemäßes substituiertes Tetrahydronaphthalin oder dessen Derivat und die Verwendung der erfindungsgemäßen substituierten Tetrahydronaphthaline und deren Derivate als MCH-Antagonisten.
Abstract:
This disclosure describes methods of reducing hydroxymethylfurfural ether and ester derivatives to produce, in the case of ethers, 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2 -methanol derivatives, or in the case of esters, 5-(acyloxymethyl)- tetrahydrofuran-2 -methanol and 5-(acyloxymethyl)- furan-2- methanol derivatives. Exemplified methods describe purification thereof. In addition, the disclosure relates to n-alkoxy hexane diol compounds, which are derivative compounds useful for replacement of petroleum based carbitol compounds, and can be made by further reduction of the 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2-methanol derivatives. The compounds made by the methods of the present teaching are useful as solvents and as starting materials for making other compositions that meet the requirements of bio-based industrial chemicals from renewable resources.
Abstract:
This disclosure describes methods of reducing hydroxymethylfurfural ether and ester derivatives to produce, in the case of ethers, 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2 -methanol derivatives, or in the case of esters, 5-(acyloxymethyl)- tetrahydrofuran-2 -methanol and 5-(acyloxymethyl)- furan-2- methanol derivatives. Exemplified methods describe purification thereof. In addition, the disclosure relates to n-alkoxy hexane diol compounds, which are derivative compounds useful for replacement of petroleum based carbitol compounds, and can be made by further reduction of the 5-(alkoxymethyl)-tetrahydrofuran-2- methanol and (5-alkoxymethyl)-furan-2-methanol derivatives. The compounds made by the methods of the present teaching are useful as solvents and as starting materials for making other compositions that meet the requirements of bio-based industrial chemicals from renewable resources.
Abstract:
The present invention provides inventive compounds of formulae (I) and (II), pharmaceutically acceptable forms thereof, pharmaceutical compositions thereof, and methods for treatment and their use.
Abstract:
Disclosed are compounds, compositions and methods for treatingFlaviviridae family virus infections. Formulae (I), (II) and (III) wherein: B and D are independently N or C-L 1 -R 1 ; with the proviso that at least one of B or D is N or CH; A and E are independently N or C-R 2 .
Abstract:
The present invention relates to l H-Quinazoline-2,4-diones of formula (I) wherein R 1 and R 2 are as defined in the specification, their preparation, their use as AMPA-receptor ligands, in particular for the treatment of epilepsy or schizophrenia, and pharmaceutical compositions containing them. Further, intermediates for the manufacture of compounds of formula (I) and combinations comprising compounds of formula (I) are disclosed.
Abstract:
Use of compounds to inhibit hormone-sensitive lipase, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.
Abstract:
Efficient synthetic methods towards mixed aliphatic carbonates through the three component couplings of aliphatic alcohols, alkyl halides and carbon dioxide in the presence of cesium carbonate and tetrabutylammonium iode (TBAI). Due to their enhanced nucleophilicities, cesium alkoxides are smoothly incorporated into CO2, allowing for mild reaction conditions such as ambient temperatures and short reaction durations. Various primary and secondary substrates are compatible under the standard conditions, offering high yields, while chiral templates such as alpha -hydroxy carbonyls are resistant to racemization.
Abstract:
Green fluorescent protein or fluorescent variants thereof are combined with ligands for use as labeled markers in detection of targets. Suitable ligands include nucleic acid probes, antibodies, hapten conjugates, biotin, avidin and streptavidin. Techniques such as fluorescent microscopy are used to visualize the labeled marker.